Showing results (11-20 of 65) with videos related to
Sort By:
Pageof 7
Pharmacological Research|November 20, 2022
Properties of FDA-approved small molecule protein kinase inhibitors: A 2023 updateRobert RoskoskiPharmacological Research|February 23, 2019
Targeting ERK1/2 protein-serine/threonine kinases in human cancersRobert RoskoskiPharmacological Research|January 29, 2021
Properties of FDA-approved small molecule protein kinase inhibitors: A 2021 updateRobert RoskoskiPharmacological Research|March 8, 2022
Targeting BCR-Abl in the treatment of Philadelphia-chromosome positive chronic myelogenous leukemiaRobert RoskoskiPharmacological Research|December 18, 2021
Properties of FDA-approved small molecule protein kinase inhibitors: A 2022 updateRobert RoskoskiBiochemical and Biophysical Research Communications|October 27, 2004
Src protein-tyrosine kinase structure and regulationRobert RoskoskiPharmacological Research|December 4, 2024
Targeted and cytotoxic inhibitors used in the treatment of breast cancerRobert RoskoskiPharmacological Research|October 19, 2024
Targeted and cytotoxic inhibitors used in the treatment of lung cancersRobert RoskoskiCritical Reviews in Oncology/Hematology|February 28, 2007
Vascular endothelial growth factor (VEGF) signaling in tumor progressionRobert RoskoskiPharmacological Research|November 27, 2019
The role of fibroblast growth factor receptor (FGFR) protein-tyrosine kinase inhibitors in the treatment of cancers including those of the urinary bladderRobert RoskoskiPageof 7